Can a patient with a codeine allergy receive Dilaudid (hydromorphone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A patient with a codeine allergy can typically receive Dilaudid (hydromorphone) safely, as it belongs to a different chemical subclass of opioids and does not share the same metabolic pathways that often trigger allergic reactions. According to the most recent and highest quality study available 1, codeine is a prodrug that requires conversion to morphine by the liver enzyme CYP2D6, whereas hydromorphone is a semi-synthetic opioid with a different molecular structure.

Some key points to consider:

  • True allergic reactions to opioids are relatively rare, and when they do occur, they're usually specific to one chemical subclass rather than representing cross-reactivity across all opioids 1.
  • Hydromorphone has properties similar to morphine and is available in various formulations, including oral, parenteral, and rectal delivery 1.
  • The patient should be monitored for any adverse reactions when first receiving Dilaudid, especially if they have a history of multiple drug allergies or severe allergic reactions.
  • If the patient has experienced only side effects from codeine (like nausea or constipation) rather than a true allergic reaction, the risk of problems with Dilaudid is even lower.

It's essential to note that caution is still warranted, and the prescribing physician should be informed about the codeine allergy. Additionally, the patient's medical history and current condition should be taken into account when making a decision about administering Dilaudid. As stated in the study 1, opioids with no active metabolites are preferred for patients with renal insufficiency or ESRD, and hydromorphone should be used with caution and adjusted dosage in these cases.

From the Research

Opioid Allergy and Cross-Reactivity

  • The risk of cross-reactivity between different opioid classes is low, with rates ranging from 0% to 6.7% 2
  • A study found that 92.5% of patients with historical opioid allergies tolerated readministration of opioids despite a chart-documented allergy 2
  • Opioid allergy labels are often unsubstantiated in clinical practice, and the removal of erroneous labels is important for pain management 3

Codeine Allergy and Alternatives

  • Codeine is a prodrug that owes its analgesic effect to its metabolite morphine, and genetic polymorphisms can contribute to unpredictable pharmacokinetics 4, 5
  • Due to the risks associated with codeine, particularly in pediatric patients, regulatory bodies have issued warnings and restrictions on its use 4, 5
  • Alternative pain control drugs and strategies are available and can be used to ensure adequate pain control in patients with codeine allergies or intolerances 4, 5

Hydromorphone (Dilaudid) and Codeine Allergy

  • There is no direct evidence to suggest that a patient with a codeine allergy cannot receive hydromorphone (Dilaudid) 3, 2
  • However, it is essential to consider the individual patient's medical history, allergy profile, and potential cross-reactivity between opioids when making prescribing decisions 3, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical Manifestations and Diagnostic Evaluation of Opioid Allergy Labels - A Review.

Journal of pain & palliative care pharmacotherapy, 2019

Research

Doing without codeine: why and what are the alternatives?

Italian journal of pediatrics, 2014

Research

Codeine: Time to Say "No".

Pediatrics, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.